Educational information, not medical advice — ask your doctor or midwife.
Glutathione is often called the body's master antioxidant — a tripeptide made from three amino acids (glycine, cysteine, and glutamate) that every cell in your body produces and depends on. IV glutathione therapy bypasses the digestive system entirely, delivering the active reduced form straight into the bloodstream where it becomes immediately available to cells. This makes it fundamentally different from oral glutathione supplements, which have limited absorption on their own.
Once in the bloodstream, reduced glutathione neutralizes harmful free radicals, helps the liver package and eliminate toxins, and recycles other antioxidants like vitamins C and E back into active form. It also supports the immune system by keeping white blood cells functioning well and plays a central role in DNA repair and protein synthesis. Because oxidative stress underlies so many modern health problems — from chronic fatigue to skin aging — restoring glutathione levels intravenously gives the body a meaningful biochemical reset.
IV glutathione is administered either as a slow drip (diluted in saline over 30–60 minutes) or as an IV push (injected over 5–15 minutes). Slow drips are generally preferred for tolerability and more consistent tissue distribution. It is sometimes included as part of a broader nutrient IV cocktail alongside vitamin C, B vitamins, or magnesium.
Glutathione infusions were first used medically in oncology and hepatology settings — supporting patients undergoing chemotherapy and those with liver disease. Over the past two decades, IV glutathione has moved into integrative and aesthetic medicine, particularly for skin brightening, anti-aging, and chronic fatigue protocols. It is widely used in clinical settings across the US, Philippines, Japan, and parts of Europe.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.